Biomedical Engineering Reference
In-Depth Information
28. Ferrarotti I, Zorzetto M, Beccaria M, Gile LS, Porta R, Ambrosino N, et al.
Tumour necrosis factor family genes in a phenotype of COPD associated with
emphysema. Eur Respir J 2003; 21(3):444-449.
29. Kusano K, Miyaura C, Inada M, Tamura T, Ito A, Nagase H, et al. Regulation
of matrix metalloproteinases (MMP-2, -3, -9, -13) by interleukin-1, interleukin-
6 in mouse calvaria: association of MMP induction with bone resorption.
Endocrinology 1998; 139(3):1338-1345.
30. Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Respir J
2001; 34:50s-59s.
31. Rusznak C, Mills PR, Devalia JL, Sapsford RJ, Davies RJ, Lozewicz S. Effect
of cigarette smoking on the permeability and IL-1 beta and slCAM-1 release
from cultured human bronchial epithelial cells of never smokers, smokers and
patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol
Biol 2000; 23(4):530-536.
32. Lucey EC, Keane J, Kuang PP, Snider GL, Goldstein RH. Severity of
elastase-induced emphysema is decreased in tumour necrosis factor-
a
and
interleukin-1
b
receptor deficient mice. Lab Invest 2002; 82:79-85.
33. Henderson WR. The role of leukotrienes in inflammation. Ann Intern Med
1994; 121:684-697.
34. Borgeat PE, Krump E, Palmanieir R, Picard S, Dallaire N, McDonald P, et al.
The synthesis of leukotrienes by the human neutrophil. In: Holgate S, ed.
SRS-A to Leukotrienes; the Dawning of a New Treatment. Oxford: Blackwell,
2003:69-84.
35. Crooks SW, Stockley RA. Leukotriene B4. Int J Biochem Cell Biol 1998;
30:173-178.
36. Ford-Hutchinson A, Bray MA, Doig MV, Shipley ME, Smith MJ. Leuko-
triene B, a potent chemokinetic and aggregating substance released from poly-
morphonuclear leukocytes. Nature 1980; 286:264-265.
37. Tonnesen MG, Anderson DC, Springer TA, Knedler A, Avdi N, Henson PM.
Adherence of neutrophils to cultured human microvascular endothelial cells.
Stimulation by chemotactic peptides and lipid mediators and dependence
upon the Mac-1, LFA-1, p150,95 glycoprotein family. J Clin Invest
1989;(83):637.
38. Nohgawa M, Sasada M, Maeda A, Asagoe K, Harakawa N, Takano K, et al.
Leukotriene B4 activated endothelial cells promote transendothelial neutro-
phil migration. J Leukoc Biol 1997; 62:203-209.
39. Beeh KM, Kommann O, Buhl R, Culpitt SV, Giembycz MA, Barnes PJ.
Neutrophil chemotactic activity of sputum from patients with COPD; role
of interleukin-8 and Leukotriene B4. Chest 2003; 123(4):1240-1247.
40. Lee E, Lindo T, Jackson N. Reversal of human neutrophil survival by leuko-
triene B4 receptor blockade and 5-lipoxygenase activating protein inhibitors.
Am J Respir Crit Care Med 1999; 160:2070-2085.
41. Feinmark SJ, Lindgren JA, Claesson HE, Malmsten C, Samuelsson B. Stimu-
lation of human leukocyte degranulation by leukotriene B4 and its omega-
oxidized metabolites. FEBS Lett 1981; 136:141-144.
